Literature DB >> 2882600

Beta blockers and lipoproteins: a review of current knowledge.

R J Northcote, I C Todd, D Ballantyne.   

Abstract

Mesh:

Substances:

Year:  1986        PMID: 2882600     DOI: 10.1177/003693308603100402

Source DB:  PubMed          Journal:  Scott Med J        ISSN: 0036-9330            Impact factor:   0.729


× No keyword cloud information.
  7 in total

Review 1.  The applied pharmacology of beta-adrenoceptor antagonists (beta blockers) in relation to clinical outcomes.

Authors:  J D Fitzgerald
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

2.  Beta blockers, lipids, and coronary atherosclerosis.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-16

3.  Beta blockers, lipids, and coronary atherosclerosis.

Authors:  A Ramani; S Nayak; G N Kundaje; A R Aroor
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-30

4.  Beta blockers, lipids, and coronary atherosclerosis: fact or fiction?

Authors:  R J Northcote
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-12

5.  Species differences in the proportion of plasma lipoprotein lipid carried by high-density lipoproteins influence the distribution of free and liposomal nystatin in human, dog, and rat plasma.

Authors:  M Ramaswamy; T L Wallace; P A Cossum; K M Wasan
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

Review 6.  Goals of antihypertensive therapy.

Authors:  G E McVeigh; J Flack; R Grimm
Journal:  Drugs       Date:  1995-02       Impact factor: 9.546

7.  Differences in the lipoprotein distribution of free and liposome-associated all-trans-retinoic acid in human, dog, and rat plasma are due to variations in lipoprotein lipid and protein content.

Authors:  K M Wasan; M Ramaswamy; S P Ng; W Wong; S C Parrott; J O Ojwang; T Wallace; P A Cossum
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.